CellBion Co., Ltd. (KOSDAQ:308430)
South Korea · Delayed Price · Currency is KRW 15,000
+260 (1.76%)
At close: Aug 14, 2026
CellBion Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,146 | 1,945 | 2,290 | 1,471 | 1,763 | 916.88 | |
Revenue Growth | -18.37% | -15.05% | 55.64% | -16.54% | 92.27% | -32.61% |
Cost of Revenue | 2,268 | 1,862 | 1,327 | 1,158 | 1,559 | 1,044 |
Gross Profit | -122.13 | 83.39 | 963.28 | 313.52 | 203.57 | -126.94 |
Selling, General & Admin | 3,758 | 3,235 | 2,711 | 1,968 | 2,443 | 2,017 |
Research & Development | 5,261 | 4,956 | 5,270 | 3,389 | 2,976 | 2,340 |
Amortization of Goodwill & Intangibles | 10.79 | - | - | - | - | - |
Other Operating Expenses | 153.76 | 136.31 | 118.08 | - | 87.86 | 66.61 |
Operating Expenses | 9,474 | 8,328 | 8,100 | 5,357 | 5,507 | 4,423 |
Operating Income | -9,596 | -8,245 | -7,137 | -5,043 | -5,303 | -4,550 |
Interest Expense | -638.54 | -137.03 | -535.88 | -140.18 | -352.51 | -276.8 |
Interest & Investment Income | 913.57 | 813.93 | 405.33 | 1,542 | 124.2 | 36.07 |
Currency Exchange Gain (Loss) | 0.03 | 1.48 | - | - | -0.13 | 0.01 |
Other Non Operating Income (Expenses) | 17,065 | -7.37 | -0.2 | 9.06 | -1,014 | 13.34 |
EBT Excluding Unusual Items | 7,744 | -7,574 | -7,267 | -3,633 | -6,546 | -4,778 |
Gain (Loss) on Sale of Assets | 5.21 | -0.03 | 1.29 | - | - | -0 |
Other Unusual Items | - | - | - | - | 164.1 | - |
Pretax Income | 7,749 | -7,574 | -7,266 | -3,633 | -6,382 | -4,778 |
Net Income | 7,749 | -7,574 | -7,266 | -3,633 | -6,382 | -4,778 |
Net Income to Common | 7,749 | -7,574 | -7,266 | -3,633 | -6,382 | -4,778 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | - | 13 | 10 | 10 | 10 | 9 |
Shares Outstanding (Diluted) | - | 13 | 10 | 10 | 10 | 9 |
Shares Change | - | 26.24% | 2.27% | 2.28% | 10.36% | 1.48% |
EPS (Basic) | - | -591.00 | -715.78 | -366.00 | -657.64 | -543.34 |
EPS (Diluted) | - | -591.00 | -716.00 | -366.00 | -658.00 | -543.34 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -10,688 | -7,018 | -4,904 | -4,240 | -5,074 | -3,572 |
Free Cash Flow Per Share | - | -547.60 | -483.08 | -427.15 | -522.88 | -406.23 |
Gross Margin | -5.69% | 4.29% | 42.07% | 21.31% | 11.55% | -13.84% |
Operating Margin | -447.23% | -423.87% | -311.67% | -342.79% | -300.83% | -496.28% |
Profit Margin | 361.16% | -389.38% | -317.32% | -246.92% | -362.02% | -521.08% |
Free Cash Flow Margin | -498.13% | -360.79% | -214.16% | -288.18% | -287.84% | -389.58% |
EBITDA | -8,949 | -7,995 | -6,922 | -4,842 | -4,944 | -3,900 |
EBITDA Margin | - | - | - | - | -280.44% | - |
D&A For EBITDA | 646.41 | 249.4 | 215.01 | 201.75 | 359.53 | 650.52 |
EBIT | -9,596 | -8,245 | -7,137 | -5,043 | -5,303 | -4,550 |
Advertising Expenses | - | 9.91 | 5.27 | - | 7.57 | 7.85 |